BridgeMD
Tests treatment safety and results for Hypoxia
Official title The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic Bronchoscopy
ClinicalTrials.gov ID: NCT07389083
What this study is testing
- What it's testing
- Bronchoscopy is now widely used for the diagnosis and treatment of various respiratory diseases. However, the procedure is highly stimulating and provokes a strong stress response; because the airway is shared, patients are prone to hypoxia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Undergoing fiberoptic bronchoscopy under deep sedation.
- Written informed consent obtained from the patient or their legal representative.
- Clear understanding of, and voluntary participation in, the study, with informed-consent form signed by the patient or their legal representative.
You likely can't join if
- Age \< 18 years
- BMI \> 30 kg/m²
- Previous history of abnormal recovery from anesthesia/surgery
- History of recurrent epistaxis, nasal bone fracture, nasal polyps, or sinus surgery
- Chronic use of opioid analgesics, benzodiazepine hypnotics, or antidepressant medications
- Known allergy to any of the anesthetic agents employed
See the full eligibility criteria
- Undergoing fiberoptic bronchoscopy under deep sedation.
- Written informed consent obtained from the patient or their legal representative.
- Clear understanding of, and voluntary participation in, the study, with informed-consent form signed by the patient or their legal representative.
- Age \< 18 years
- BMI \> 30 kg/m²
- Previous history of abnormal recovery from anesthesia/surgery
- History of recurrent epistaxis, nasal bone fracture, nasal polyps, or sinus surgery
- Chronic use of opioid analgesics, benzodiazepine hypnotics, or antidepressant medications
- Known allergy to any of the anesthetic agents employed
- Anticipated difficult airway
- Increased intracranial pressure
- Active upper-respiratory-tract infection of the oral, nasal, or pharyngeal regions
- Severe cardiac insufficiency (functional capacity \< 4 METs)
- Severe renal failure requiring dialysis prior to surgery
- Pre-operative oxygen saturation on room air \< 92 %
- Any condition that, in the opinion of the investigator, renders the patient unsuitable for participation in this trial
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.